“While oral cholera vaccination is important, it is one of several tools to curb the ongoing outbreak,” says Dr Humphrey ...

OUR county is a cosmopolitan, ethnically-rich and diverse community that has benefited enormously from multiculturalism.

High-burden cholera outbreaks, spreading beyond the traditional cholera-endemic countries, have been reported since 2021 in ...

Ghana is currently battling a cholera outbreak that began in October 2024, with the first case reported in the Greater Accra ...

Valneva’s growth potential lies in Ixchiq, but risks remain. Find out why VALN stock is still a Buy with a good long-term ...

H.C. Wainwright analyst Edward White reiterated a Buy rating on Valneva (VALN – Research Report) today and set a price target of $18.00.Invest ...

Thirteen years of extended conflict, economic downturns, and multiple earthquakes, has left Syria in the midst of a severe humanitarian crisis. Hostilities remain abundant across all of Syria’s ...

From 1 January to 29 December 2024, a cumulative total of 804 721 cholera cases and 5805 deaths were reported from 33 countries across five WHO regions. The number of cases and deaths in December 2024 ...

Kepler Capital analyst Justine Telliez maintained a Buy rating on Valneva (0OB3 – Research Report) on January 21 and set a price target of ...

Emergent BioSolutions (NYSE:EBS – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Friday. Several other equities ...

Valneva (NASDAQ:VALN – Free Report) had its price target cut by HC Wainwright from $19.00 to $18.00 in a report released on Thursday,Benzinga reports. They currently have a buy rating on the stock. HC ...